Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene modulation therapy utilizing regulation of epigenetic genome for a variety of diseases.
Epigenic Therapeutics raises $60M in Series B funding
Epigenic Therapeutics secures $60M Series B funding for epigenetic medicine development, led by Lapam Capital with participation from existing and new investors.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.